Professional Documents
Culture Documents
Report
Report
Report
General metrics
19,620 2,812 170 11 min 14 sec 21 min 37 sec
characters words sentences reading
speaking
time time
99 2 1 1
Issues left Critical Advanced
Plagiarism
This text hasn’t been checked for plagiarism
Writing Issues
2 Correctness
1 Confused words
1 Incomplete sentences
3. To reduce the severity of his Crohn's disease, Simon should follow the
treatment plan, which includes a healthy diet, regular exercise, social support,
and medication.
Discuss and Critically Analyse Consumer Directed Care/Self-Management
The term "consumer-directed care" (CDC) or "Self-Management" refers to a set
of practices in nursing informatics and planning that provide patients and their
caretakers greater involvement in how they are cared for (Wildman et al., 2021).
According to Wildman et al. (2021), Consumer-directed care and self-
management planning are crucial if Simon and other patients like him are to
maintain their independence in the community. If care for the client is well-
organised, they may be able to maintain their health and independence for a
more extended period (Logan et al.,2020). Although self-management
education interventions for Crohn's disease have been created, their efficacy
has not been extensively examined.
The Centres for Disease Control and Prevention (CDC) are based on many key
ideas;
1. Enhanced capacity for adaptation and natural selection.
2. An increase in people's capacity to receive the necessary data to make well-
informed health-related decisions, such as treatments to seek out, which
providers to work with, and how these therapies will be offered.
3. More open communication and teamwork between healthcare providers and
patients may improve patient health and patients' ability to make treatment
decisions. The CDC's primary objective is to promote self-sufficiency among its
constituents. By reversing the traditional decision-making sequence and
providing residents with more involvement in day-to-day challenges, this
empowerment aims to promote individual autonomy and quality of life.
Furthermore, he must be sensitised to the point where he can notice the signs
of discomfort and understands when to seek expert treatment. Simon, now an
adult, must shoulder the psychological and interpersonal demands of self-care
for the lifetime of his chronic condition (Al-Yateem et al., 2016). His loved ones
and the individuals under his care must support him. Furthermore, he needs a
strategy outlining his self-management technique and what to do in the event
of aggravation. To combat chronic malnutrition, vitamin deficiencies, and
possibly fatal GIT and urinary tract infections resulting from Crohn's disease,
high-frequency percussion is used with other drugs and treatments (Attauabi
et al.,2021). There is a need for a GIT physiotherapist and a clinical nurse expert
to assess his health. Some people with Crohn's disease experience early-onset
symptoms, such as constipation (which can develop into bowel blockage),
chronic diarrhoea, and stomach cramps and discomfort; nevertheless, these
signs are not caused by the illness but rather by external factors.
Consumer-guided care/self-management planning is essential for patients
with chronic diseases like Crohn's disease who wish to maintain their
functional autonomy. An excellent care plan can help the individual stay
healthy and independent by informing them about their chronic condition,
instructing them in the proper use of drugs and other treatments (such as
physical therapy), and alerting them to the earliest indications of decline
(Kammermeier et al.,2016). Healthcare planning in which the patient is involved
plays an instrumental part in making decisions, also known as consumer-
directed care or chronic disease self-management planning (CDT/SMP), which
is increasingly becoming the norm in the medical community (Vernia et
al.,2020). The training should cover the individual's medications, dosage
instructions, and a discussion of any possible side effects.
Nutritional adherence
SMART GOAL 1:
SMART GOAL 2:
Simon should ensure that every food he eats contains fibre daily. Foods rich in
soluble fibre can help him slow his digestion and ease diarrhoea.
SMART GOAL 3:
Simon should take a multivitamin daily to boost his body's vitamin stores and
availability (Ding et al., (2016).
Abdominal pain management by using analgesics Panadol PRN for 14 days
Simons' vital signs, such as heart rate, blood pressure, respiratory rate, and
muscle tone or posture, return to normal within a week.
Effective nutrition management and fewer carbohydrates are both possible for
Simon's education on nutritional management (Chateau & Peyrin-Biroulet,
2020).
Simon has been given prednisolone to increase his immune system and bring
down the inflammation in his colon. Disease development can be halted by
patient adherence to medication (Bullock et al., 2018). Simon must follow the
prescribed course of treatment. It is necessary to develop the ability to keep
medication on one's habits regarding medication non-adherence and replace
those unhealthy ones with ones that promote more confidence in one's abilities
(Adamina et al.,2020).
Simon needs to take his medication each day without fail timely.
The symptoms will worsen if the medication is not taken as prescribed. Simon
has to learn to self-manage the medicine he takes to lower his risk of
developing poor QoL and mental health issues due to his limited mobility and
poor self-care (Adamina et al.,2020).
During dressing the peripherally inserted central catheter, the insertion site
should be checked for signs of infection every two days for redness or swelling.
Simon must examine the dressing to guarantee it is clean and in good shape.
The dressing may need to be changed if it shows signs of wear and tear, such as
peeling edges, dirt, or blood.
Self-management of Crohn's disease via a multidisciplinary team (MDT) or
other health specialists.
Simon needs to be exercising by using the physiotherapist after every two days.
Studies show that exercise effectively alleviates Crohn's symptoms by lowering
stress (Lu et al., 2019).
Simon needs to see a nutritionist every month so that he may make dietary
changes to help him manage the risks associated with his Crohn's disease.
Simon requires a counselling session regarding his stress for two weeks visit to
a counsellor.
His risk of mental stress and anxiety will decrease by two weeks of counselling,
and he will be more motivated to live a healthy lifestyle by sticking to a
nutritious diet, avoiding flare-ups, and prioritising his health care if he receives
psychological assistance (Logan et al.,2020).
social interaction will help him move about more efficiently and reduce the
likelihood of future deformities. Reduced body image and self-esteem are
avoided when people have access to psychosocial help (Logan et al.,2020).
1
There is a need for the counsellor to engage the relatives, such as his sons, so
show him support throughout his disease process for an hour of counselling.
His insecurities may cause him to withdraw from friends and family. These
issues stem from stress, despair, and anxiety. Better Crohn's disease
management can be achieved by increased social engagement, which he
should be encouraged to pursue (Van Rheenen et al.,2021)
Reference List
Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A.,
... & Zmora, O. (2020). ECCO guidelines on therapeutics in Crohn's disease:
surgical treatment. Journal of Crohn's and Colitis, 14(2), 155-168.
https://doi.org/10.1093/ecco-jcc/jjz187
Attauabi, M., Burisch, J., & Seidelin, J. B. (2021). Efficacy of ustekinumab for
active perianal fistulising Crohn's disease: a systematic review and meta-
analysis of the current literature. Scandinavian Journal of Gastroenterology,
56(1), 53-58.https://doi.org/10.1080/00365521.2020.1854848
Chateau, T., & Peyrin-Biroulet, L. (2020). Evolving therapeutic goals in Crohn's
disease management. United European gastroenterology journal, 8(2), 133-139.
https://doi.org/10.1177/2050640619887316
Dolinger, M. T., Person, H., Smith, R., Jachin, L., Pittman, N., Dubinsky, M. C., &
Lai, J. (2020). Pediatric Crohn's disease and multisystem inflammatory
Kammermeier, J., Morris, M. A., Garrick, V., Furman, M., Rodrigues, A., Russell,
R. K., & BSPGHAN IBD Working Group. (2016). Management of Crohn's disease.
Archives of disease in childhood, 101(5), 475–480.
https://doi.org/10.1136/archdischild-2014-307217
Kennedy, N. A., Heap, G. A., Green, H. D., Hamilton, B., Bewshea, C., Walker, G.
J., ... & Bell, A. (2019). Predictors of anti-TNF treatment failure in anti-TNF-
naive patients with active luminal Crohn's disease: a prospective, multicentre,
cohort study. The Lancet Gastroenterology & hepatology, 4(5), 341–353.
https://doi.org/10.1016/s0016-5085(18)30617-6
Logan, M., Gkikas, K., Svolos, V., Nichols, B., Milling, S., Gaya, D. R., ... &
Gerasimidis, K. (2020). Analysis of 61 exclusive enteral nutrition formulas used
in managing active Crohn's disease—new insights into dietary disease triggers.
Alimentary pharmacology & therapeutics, 51(10), 935-947.
https://doi.org/10.1111/apt.15695
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., &
Sands, B. E. (2018). ACG clinical guideline: management of Crohn's disease in
adults. Official journal of the American College of Gastroenterology| ACG,
113(4), 481-517. https://doi.org/10.1038/ajg.2018.27
Lu, C., Holubar, S. D., & Rieder, F. (2019). How I approach the management of
2
structuring Crohn's disease. Official journal of the American College of
Gastroenterology| ACG, 114(8), 1181-1184.
https://doi.org/10.14309/ajg.0000000000000199
Schreiber, S. W., Ferrante, M., Panaccione, R., Colombel, J. F., Hisamatsu, T.,
Lim, A., ... & D'Haens, G. R. (2021). OP26 Risankizumab induces early clinical
remission and response in patients with Moderate-to-Severe Crohn's Disease:
Results from the phase 3 ADVANCE and MOTIVATE studies. Journal of Crohn's
and Colitis, 15(Supplement_1), S026-S027. https://doi.org/10.1093/ecco-
jcc/jjab075.025
Vernia, F., Di Ruscio, M., Stefanelli, G., Viscido, A., Frieri, G., & Latella, G. (2020).
Is faecal calprotectin an accurate marker in the management of Crohn's